Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Family Doctors Day Bern

Anxiety disorders and depression are difficult to distinguish

    • Congress Reports
    • Psychiatry and psychotherapy
    • RX
  • 3 minute read

Two diseases or one clinical picture with different facets? This question remained unanswered at the Bern GP Conference in Bern. In contrast, there were important recommendations for managing anxiety disorders and depression in family practice.

(rs) The lifetime prevalence of anxiety disorders is approximately 15%, with women affected twice as often as men, similar to depression. Questionnaires are an important screening method that can rapidly identify psychiatric disorders, even in family practice. The health questionnaire [1], which includes questions about depression and anxiety, was given as an example.

Differential diagnosis must exclude an organic disorder as the cause of anxiety. Anxiety occurs as an associated symptom in various endocrine and metabolic disorders, as well as pulmonary, cardiac, or cerebral disease. An organic cause is supported by an age below 18 and above 35 years, the absence of other psychological symptoms or a current stressor, and a fluctuation that correlates with the duration and severity of the physical illness.

Early anxiety disorders are not only a massive risk factor for the onset of later depression. Due to overlapping symptoms, the two diseases are also difficult to separate therapeutically. A typical symptom of depression, in addition to sadness and listlessness, is anhedonia. “It’s not just the appetite that’s wrong, it’s the appetence,” said Prof. Thomas Müller, MD, medical director of the Polyclinic of the University Department of Psychiatry and Psychotherapy, at the GP Day in Bern. This means that some people continue to eat despite the depression, but they do not feel any pleasure in doing so. In order to exclude an organic cause such as dementia, brain tumor, craniocerebral trauma or the symptomatic occurrence of depression, e.g. postoperative, postinfectious or pharmacogenic, additional technical examinations are often necessary in addition to the survey of the physical-neurological findings.

Do not postpone medication changes for too long

Psychoeducation is an important intervention in anxiety treatment. “Often the clarification and counseling already has a significant anxiety-relieving effect,” Prof. Müller said. Specific psychotherapies, e.g., various behavioral therapies, had also been shown to be very effective. In pharmacotherapy, antidepressants such as serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclic antidepressants such as clomipramine are most commonly used. Benzodiazepines should be used only in emergencies or for crisis intervention. Current research is focused on developing benzodiazepine-like drugs that bind to specific subreceptors for anxiety relief but have no addictive potential. The active substance pregabalin belongs to the already approved drugs of this group of so-called α-2-δ-ligands.

The most important goal in depression treatment is to overcome the acute phase, by means of anxiety relief and sleep protection. “If you can’t sleep, you don’t get better,” the speaker said. Pharmacological treatment should be given according to guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP). It is also important to maintain regular contact with those affected and to record suicidal tendencies. If no improvement is seen after ten to 14 days of pharmacological treatment, a change of medication or lithium augmentation is recommended. “In doing so, one should not wait too long,” says Prof. Müller. In addition, a psychiatrist should be consulted. Psychotherapy can be helpful in terms of support and motivation at the beginning. After the symptoms have subsided, the question arises as to how long the medication should be continued. Studies have shown long-term pharmacotherapy to be beneficial. “In the worst case, however, this also means longer side effects,” Prof. Müller said. “In any case, it is recommended to continue medication for six to nine months, if possible up to a year after the acute symptoms have resolved.”

Source: Bern GP Day, March 13, 2014, Bern

Literature:

  1. Health questionnaire: www.klinikum.uni-heidelberg.de/fileadmin/medizinische_klinik/Abteilung_2/pdf/Komplett_PHQ_Fragebogen.pdf

HAUSARZT PRAXIS 2014; 9(5): 45-46

Autoren
  • Regina Scharf
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Anxiety disorder
  • Anxiety disorder
  • Bern
  • Depression
  • Family doctor
  • Family Physicians Day
  • Lifetime prevalence
Previous Article
  • Alcohol dependence treatment

Establish reduction of alcohol consumption as a therapy goal

  • Congress Reports
  • Prevention and health care
  • Psychiatry and psychotherapy
  • RX
View Post
Next Article
  • Job description family doctor

David, Goliath or Hercules after all?

  • Congress Reports
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Evidence-based therapy for psoriasis in difficult locations

IL-23 inhibition in scalp psoriasis: what’s new?

    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Obesity in the family practice

Aim for realistic goals and avoid apportioning blame

    • Congress Reports
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 9 min
  • Evidence, pathophysiology and management in the light of current data

Heart failure with improved ejection fraction (HFimpEF)

    • Cardiology
    • Education
    • Radiology
    • RX
    • Studies
View Post
  • 5 min
  • Early rheumatoid arthritis

C1M has potential as a biomarker

    • Education
    • General Internal Medicine
    • Geriatrics
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Osteoporosis

Risk-stratified therapy with osteoanabolic agents improves outcomes

    • Congress Reports
    • General Internal Medicine
    • Geriatrics
    • Pharmacology and toxicology
    • Rheumatology
    • RX
View Post
  • 2 min
  • "Swiss Health Care Atlas"

New indicator: medication for weight regulation

    • Endocrinology and Diabetology
    • Practice Management
    • Prevention and health care
    • RX
View Post
  • 20 min
  • AI in neurology

Control instead of a flood of data: AI makes big data and wearables usable

    • Cardiology
    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 7 min
  • Longevity Medicine 2025

From anti-ageing to precision prevention

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Hematology
    • Infectiology
    • Nutrition
    • Oncology
    • Orthopedics
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Prevention and health care
    • Rheumatology
    • RX
    • Studies
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Music therapy in Swiss oncology
  • 2
    Causes and prevention at work
  • 3
    Yellow nail and Swyer-James syndrome
  • 4
    Recommendations for action in practice
  • 5
    From the β-cell to the center: the versatile role of amylin

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.